SCHEMBL6153596

SCHEMBL6153596

COc1ccc2c(Cc3ccc(OCCC4CCCN4)cc3)c(-c3ccc(Cl)cc3Cl)c(=O)oc2c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.51
DRD2 P14416 2/20 0.40
DRD4 P21917 2/20 0.40
DRD3 P35462 1/20 0.40
ESR1 P03372 6/20 0.40
LTA4H P09960 2/20 0.39
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
ACHE P22303 3/20 0.38
ESR2 Q92731 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
BCHE P06276 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5983904 0.91 ESR1 (0.48) CYP19A1ESR1LTA4HESR2
SCHEMBL6152455 0.90 CYP19A1 (0.44) CYP19A1DRD2DRD4DRD3ESR1
SCHEMBL5426736 0.85 ESR1 (0.57) CYP19A1DRD2DRD4DRD3ESR1
SCHEMBL4639676 0.84 CYP19A1 (0.58) CYP19A1DRD2DRD4DRD3ESR1
SCHEMBL4640645 0.84 HSP90AA1 (0.39) CYP19A1ESR1LTA4H
SCHEMBL6158194 0.81 ESR1 (0.45) ESR1ESR2
SCHEMBL6152270 0.81 ESR1 (0.47) ESR1ESR2
SCHEMBL6152326 0.81 CYP19A1 (0.51) CYP19A1DRD2DRD4DRD3ESR1
SCHEMBL4639596 0.81 CYP19A1 (0.62) CYP19A1ESR1ESR2
SCHEMBL5142313 0.79 ESR1 (0.50) CYP19A1DRD2DRD4DRD3ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497277-A1 BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals, Inc. (US) 2005-01-19 EP disclosed
WO-2003089422-A1 BENZOPYRANONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, INC. (US) 2003-10-30 WO disclosed